Shimla Online

Delveinsight Business Research LLP

Neuropathic pain (NP) is now defined by the International Association for the Study of Pain (IASP) as ‘pain caused by a lesion or disease of the somatosensory nervous system.’ This replaces the older definition of ‘pain initiated or caused by a primary lesion, dysfunction or transitory perturbation of the peripheral or central nervous system.

Depending on the symptoms, doctors may do tests to check for disorders that could be causing the pain. Tests may include magnetic resonance imaging (MRI), nerve conduction studies, electromyography (EMG), and blood tests. Nerve conduction studies and EMG help doctors determine whether pain results from a problem with muscle or nerves.

Get FREE sample copy at:  https://www.delveinsight.com/sample-request/neuropathic-pain-market

The Neuropathic Pain Market Research Report covers emerging drugs, current treatment practices, market share of the individual therapies, current and forecasted Neuropathic Pain market Size from 2017 to 2030 segmented by seven major markets. 

The report provides a detailed current Neuropathic Pain treatment practice/algorithm, market drivers, market barriers, and unmet medical needs to curate the best of the opportunities and assess the underlying potential of the market. 

Neuropathic Pain Market Key Facts

• As per the International Association for the Study of Pain (2014–2015), of the 33 million people affected with HIV across the world, around 35% had neuropathic pain, which did not respond well to standard treatments.

• As per the article by Bouhassira (2018) titled “Neuropathic pain: Definition, assessment and epidemiology,” epidemiological studies have shown that their prevalence in the general population may be as high as 7–8%, accounting for 20–25% of individuals with chronic pain.

• According to study by Nagoshi N. et al. (2015), men were more affected with neuropathic pain than women.

• In a study by Lasry-Levy (n.d), 101 patients were recruited, and 22 (21.8%) had neuropathic pain; 14/22 males (63.6%) and 8/22 females (36.3%) had neuropathic pain.

Key Benefits of Neuropathic Pain Market Report

• Neuropathic Pain market report provides an in-depth analysis of Neuropathic Pain Market Size, Share, Trend, and Epidemiology Forecast till 2030 in the seven major markets (i.e. the United States, EU5 (Germany, Italy, Spain, France, and the UK) and Japan.

• The report will help in developing business strategies by understanding the Neuropathic Pain Market Trends, recent developments, key players, and future market competition that will shape and drive the market growth in the upcoming years.

• The market report covers the Neuropathic Pain current treatment practices, emerging drugs, market share of the individual therapies in the seven major markets.

• The report provides a detailed assessment of the Neuropathic Pain market in terms of market drivers & barriers, unmet needs, market opportunities, patient population, detailed comparative analysis of pipeline products including clinical and non-clinical stage products, and other factors. 

Neuropathic Pain Market

The Neuropathic Pain market size shall grow during the forecast period owing to the launch of upcoming therapies and increased patient pool in the 7MM.

The market outlook section of the report helps to build a detailed comprehension of the historic, current, and forecasted Neuropathic Pain market size and share by analyzing the impact of current therapies on the market, unmet needs, drivers, and barriers, and demand for better technology.

The report gives a thorough detail of the Neuropathic Pain market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria, mechanism of action, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. 

Neuropathic Pain Epidemiology

The epidemiology section covers insights about the historical and current Neuropathic Pain patient pool and forecasted trends for every seven major countries from 2017 to 2030. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. The epidemiology section also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Neuropathic Pain Epidemiology Segmentation

• Total Prevalent Cases of Neuropathic Pain

• Gender-specific Prevalent Cases of Neuropathic Pain

• Cause-specific Prevalent Cases of Neuropathic Pain

• Diagnosed and Treatable Cases of Neuropathic Pain

Neuropathic Pain Drugs Uptake and Pipeline Development Activities

The drugs uptake section focuses on the rate of uptake of the potential drugs recently launched in the Neuropathic Pain market or expected to get launched in the market during the study period. The analysis covers Neuropathic Pain market uptake by drugs; patient uptake by therapies; and sales of each drug.   

Report’s Drugs Uptake section helps in understanding the drugs with the most rapid uptake, reasons behind the maximal use of new drugs and allow the comparison of the drugs on the basis of market share and size which again will be useful in investigating factors important in market uptake and in making financial and regulatory decisions.

The report also covers the Neuropathic Pain Pipeline Development Activities and provides valuable insights about different therapeutic candidates in Phase II, and Phase III stages and the key companies in the Neuropathic Pain market involved in developing targeted therapeutics. It also analyses the recent Development such as collaborations, acquisitions, and mergers, licensing patent details, and other information for Neuropathic Pain emerging therapies.

The neuropathic pain (NP) market dynamics are anticipated to change in the coming years due to the improvement in the rise in healthcare spending across the world. 

Neuropathic Pain Companies:

• Pfizer

• Vistagen Therapeutics

• Algiax Pharmaceuticals

• Centrexion Therapeutics

And many others.

Neuropathic Pain Therapies covered in the report includes

• AV-101 (4-Cl-KYN)

• ACD440

• AP-325

And many more.

Table of Content

1. Key Insights

2. Executive Summary 

3. Neuropathic Pain Competitive Intelligence Analysis

4. Neuropathic Pain Market Overview at a Glance

5. Neuropathic Pain Disease Background and Overview

6. Neuropathic Pain Patient Journey

7. Neuropathic Pain Epidemiology and Patient Population

8. Neuropathic Pain Treatment Algorithm, Current Treatment, and Medical Practices

9. Neuropathic Pain Unmet Needs

10. Key Endpoints of Neuropathic Pain Treatment

11. Neuropathic Pain Marketed Products

12. Neuropathic Pain Emerging Therapies

13. Neuropathic Pain Seven Major Market Analysis

14. Attribute Analysis

15. Neuropathic Pain Market Outlook (7 major markets)

16. Neuropathic Pain Access and Reimbursement Overview

17. KOL Views on the Neuropathic Pain Market.

18. Neuropathic Pain Market Drivers

19. Neuropathic Pain Market Barriers

20. Appendix

21. DelveInsight Capabilities

22. Disclaimer

*The table of contents is not exhaustive; the final content may vary. 

Get FREE sample copy at:  https://www.delveinsight.com/sample-request/neuropathic-pain-market

Latest Reports By DelveInsight
Neuropathic Pain Pipeline Insights
Neuropathic Pain Pipeline Insights, 2021 report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Neuropathic Pain market.

Healthcare Blog By DelveInsight
Future of Medtech and the Healthcare Industry
The MedTech industry is expected to witness growth owing to the introduction of smaller, cost-effective, wireless technologies, that along with better treatment will also ensure safety for both healthcare workers and patients. Some of the key MedTech Companies exploiting the domain and changing the market dynamics include Abbott, Medtronic, Zimmer Biomet, Johnson & Johnson, Boston Scientific, Olympus Corporation of the Americas, Smith & Nephew, Nevro, EXINI Diagnostics, and others. Visit to know how these companies are bringing in innovation and accelerating the growth of the Market: Leading Medtech Companies

About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused exclusively on life sciences. It supports pharma companies by providing end-to-end comprehensive solutions to improve their performance.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Shruti Thakur
Email: Send Email
Phone: +919650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/